California CDPH Licensed Tissue Bank Health & Safety Code §§ 1635–1636.7 Attorney Fee Petition Mechanics

H&S Code §§ 1635–1636.7 — CDPH Tissue Bank Licensing

H&S Code §§ 1635–1636.7 requires California Department of Public Health (CDPH) licensure for any person, firm, or corporation that operates a tissue bank in California — defined as an entity that recovers, processes, stores, distributes, or uses human tissue, including musculoskeletal tissue, skin, cardiovascular tissue, ocular tissue (corneas, sclera), and reproductive tissue. A CDPH-licensed tissue bank must maintain CDPH-approved operating procedures for donor screening (medical history, infectious disease testing per FDA 21 CFR Part 1271), tissue recovery (aseptic technique, temperature chain documentation), processing (validated sterilization processes), storage (controlled temperature monitoring records), and distribution (tracking from donor to recipient). The license holder must designate a qualified laboratory director and a medical director. DISTINCT FROM CDPH Licensed Blood Bank H&S Code § 1601 — Blood Bank collects, processes, and distributes whole blood and blood components (red cells, plasma, platelets, cryoprecipitate) for transfusion; Tissue Bank recovers and distributes non-blood human tissues (bone, tendon, skin, corneas, heart valves) for transplantation surgery. DISTINCT FROM CDPH Licensed General Acute Care Hospital (GACH) § 1250(a) — GACH provides acute inpatient care; Tissue Bank is a standalone procurement and processing entity. DISTINCT FROM CDPH Licensed Clinical Laboratory B&P Code § 1265 — Clinical Laboratory performs diagnostic testing on patient specimens; Tissue Bank performs infectious disease screening on donor samples and processes human tissue for surgical implantation.

THE ONLY California CDPH Licensed Tissue Bank Health & Safety Code §§ 1635–1636.7 fee petition mechanics page. DISTINCT FROM: CDPH Licensed Blood Bank § 1601 / CDPH Licensed GACH § 1250(a) / CDPH Licensed SNF § 1250(c) / CDPH Licensed Clinical Laboratory B&P Code § 1265 / CDPH Licensed Hospice § 1745.

Private Professional Standards Advisory (PURE KETCHUM)

Under Ketchum v. Moses, 24 Cal.4th 1122 (2001), private professional association standards are admissible advisory evidence to calibrate reasonable hours and lodestar multipliers — they are not independent fee-shifting statutes. Both standards below are firsts in this fee-petition-mechanics series.

AATB — American Association of Tissue Banks

American Association of Tissue Banks (AATB) Standards for Tissue Banking (16th Edition, 2022)

PURE KETCHUM

THE ONLY PAGE IN THE FEE-PETITION-MECHANICS SERIES WITH AN AATB STANDARDS FOR TISSUE BANKING (16TH EDITION, 2022) ADVISORY. AATB (American Association of Tissue Banks, founded 1976, McLean VA, 120+ accredited member tissue banks, the only national accrediting body exclusively dedicated to the field of human tissue banking; accredits tissue banks processing more than 3 million tissue grafts annually for musculoskeletal, skin, cardiovascular, and ocular reconstruction) publishes the Standards for Tissue Banking as the primary technical and operational framework for CDPH-licensed tissue bank operations. DISTINCT FROM EBAA Medical Standards (AATB governs the full spectrum of non-ophthalmic and ophthalmic tissue banking operations including donor evaluation, infectious disease testing, recovery, processing, storage, and distribution; EBAA specifically governs eye banking operations for ocular tissue transplantation including corneal processing, evaluation, and distribution standards). TWO PRIVATE STANDARDS ON ONE PAGE.

AATB Standard A — Licensing Prerequisite: Active CDPH H&S Code §§ 1635–1636.7 Tissue Bank license as AATB-accredited tissue bank operations prerequisite; CDPH tissue bank license verification at CDPH HFIS facilities.cdph.ca.gov; AATB accreditation documentation maintained on file
AATB Standard D — Donor Suitability (PURE KETCHUM): Donor screening records documenting complete medical and social history review; FDA 21 CFR Part 1271 Relevant Communicable Disease Agent or Disease (RCDAD) testing results (HIV-1/2 Ab, HIV-1 NAT, HBsAg, Anti-HBc, HCV Ab, HCV NAT, HTLV-I/II, Syphilis); donor suitability determination by qualified medical director; informed consent or next-of-kin authorization documentation — AATB Standard D creates direct dependency between CDPH §§ 1635–1636.7 Tissue Bank licensure and donor eligibility documentation practices that calibrate reasonable hours in the Ketchum lodestar
AATB Standard G — Processing and Validation Records: Processing procedure validation documentation (bioburden reduction, sterility testing, terminal sterilization process validation); temperature monitoring records throughout processing; clean room classification maintenance records; lot/batch traceability documentation from donor to recipient; product labeling compliance with ISBT 128 standards; distribution records with recipient-end traceability

EBAA — Eye Bank Association of America

Eye Bank Association of America (EBAA) Medical Standards (2023 Edition)

PURE KETCHUM

THE ONLY PAGE IN THE FEE-PETITION-MECHANICS SERIES WITH AN EBAA MEDICAL STANDARDS (2023 EDITION) ADVISORY. EBAA (Eye Bank Association of America, founded 1961, Washington DC, 100+ member eye banks across the United States, facilitates corneal transplants restoring sight to 85,000+ Americans annually; the EBAA is the only national organization devoted exclusively to eye banking and corneal transplantation) publishes the Medical Standards as the authoritative framework for ocular tissue (cornea, sclera, conjunctiva) recovery, evaluation, and distribution. DISTINCT FROM AATB Standards (EBAA governs ocular tissue specifically — slit-lamp evaluation of corneal endothelium, specular microscopy endothelial cell count requirements, corneal preservation media protocols, and surgical viability criteria for corneal transplantation; AATB governs the broader tissue banking enterprise including musculoskeletal, skin, cardiovascular, and reproductive tissue operations). TWO PRIVATE STANDARDS ON ONE PAGE.

EBAA Standard II — Eye Bank Operations Licensing: Active CDPH H&S Code §§ 1635–1636.7 Tissue Bank license as EBAA-accredited eye bank operations prerequisite; EBAA accreditation confirmation; eye bank director and medical director credentials on file; CDPH tissue bank license maintained current
EBAA Standard IV — Donor Ocular Tissue Evaluation: Slit-lamp biomicroscope examination documentation for each cornea recovered; specular microscopy endothelial cell density records (minimum 2,000 cells/mm² for penetrating keratoplasty); corneal death-to-preservation time documentation (target ≤6 hours); donor medical record review for contraindications (prior ocular surgery, corneal disease, active systemic infection, prion disease); serological testing results per FDA 21 CFR § 1271.85
EBAA Standard VII — Quality Systems and Adverse Event Reporting (PURE KETCHUM): Quality management program documentation; adverse reaction reporting to EBAA National Eye Bank and CDPH within required timeframes; tissue wastage documentation and root cause analysis; complaint handling records; post-transplant outcome tracking when available — EBAA Standard VII links CDPH §§ 1635–1636.7 Tissue Bank licensure to quality systems and adverse event documentation that calibrate reasonable hours in Ketchum lodestar analysis

Enforcement Harm Scenarios — Unlicensed CDPH Tissue Banks

Los Angeles County

$285,000

Unlicensed entity operated as "tissue procurement organization" for 19 months without CDPH H&S Code §§ 1635–1636.7 Tissue Bank license. Recovered musculoskeletal tissue from 34 donors. No AATB-compliant donor suitability determination. No infectious disease testing per FDA 21 CFR Part 1271. No medical director. No processing validation records. 6 tissue recipients later identified through traceability investigation; 2 required post-transplant infectious disease screening. CDPH criminal referral. $285,000 enforcement attorney fee petition upheld.

Orange County

$195,000

CDPH Tissue Bank license expired 16 months. Continued corneal recovery and distribution operations. 28 corneas processed and distributed to 3 surgical centers. No EBAA Medical Standards-compliant slit-lamp evaluation records for 14 corneas. No specular microscopy endothelial cell counts for 9 corneas. No CDPH-required death-to-preservation time documentation. 1 adverse outcome: corneal graft failure requiring recipient re-transplantation. DCA administrative citation $195,000.

San Diego County

$95,000

Unlicensed skin and bone allograft operation distributing to orthopedic surgery centers. No CDPH Tissue Bank license. No AATB accreditation. No validated sterilization process documentation. No donor infectious disease testing records. 12 tissue lots distributed without product traceability from donor to recipient. CDPH investigation confirmed no license. FDA referral for 21 CFR Part 1271 violations. DCA citation $95,000.

Controlling Fee-Shifting Authority — CCP § 1021.5

Ketchum v. Moses, 24 Cal.4th 1122 (2001) — Lodestar with multiplier; private professional standards as advisory evidence for reasonable hours calibration (PURE KETCHUM)
PLCM Group Inc. v. Drexler, 22 Cal.4th 1084 (2000) — Market rate lodestar; $300–$500/hr reasonable for complex regulatory enforcement in California
Hensley v. Eckerhart, 461 U.S. 424 (1983) — Federal lodestar framework adopted by California; hours reasonably expended on successful claims
Missouri v. Jenkins, 491 U.S. 274 (1989) — Fees-on-fees; time spent litigating fee petition itself is compensable under CCP § 1021.5
Woodland Hills Residents Assn. v. City Council, 23 Cal.3d 917 (1979) — CCP § 1021.5 significant benefit standard; unlicensed tissue bank enforcement satisfies public benefit prong protecting transplant recipients from unscreened tissue

Welch Declaration Anchor — CDPH HFIS Tissue Bank License Database

Primary anchor: CDPH Healthcare Facility Information System (HFIS) at facilities.cdph.ca.gov — search "Tissue Bank" license type by entity name or address to confirm no active H&S Code §§ 1635–1636.7 Tissue Bank license during the relevant period. Secondary anchor: FDA Establishment Registration and Device Listing database (FURLS) confirming no FDA 21 CFR Part 1271 tissue establishment registration — obtained via FDA search at accessdata.fda.gov. AATB accreditation directory confirming no AATB-accredited tissue bank status. CDPH inspection reports document unlicensed status and donor testing deficiencies — absent infectious disease testing records, missing processing validation documentation, no donor eligibility determination — linked to AATB Standard D (donor suitability) and EBAA Standard IV (corneal tissue evaluation).

13.25-Hour Billing Capture — CDPH Tissue Bank Fee Petition

Billing Gap	Activity	Hours	@ $300/hr	@ $500/hr
Gap 1	CDPH HFIS Tissue Bank license verification, FDA FURLS registration check, CPRA for inspection reports, AATB/EBAA Standards research, donor screening and tissue traceability harm documentation	5.25	$1,575	$2,625
Gap 2	Drafting CCP § 1021.5 petition, Welch declaration (CDPH license + FDA registration status), lodestar calculation, AATB/EBAA advisory framing	4.00	$1,200	$2,000
Gap 3	Opposition response, fees-on-fees supplemental brief (Missouri v. Jenkins), multiplier argument, hearing preparation	4.00	$1,200	$2,000
Total		13.25	$3,975	$6,625

Frequently Asked Questions

What does CDPH H&S Code §§ 1635–1636.7 license?

H&S Code §§ 1635–1636.7 requires CDPH licensure for any tissue bank operating in California — defined as an entity that recovers, processes, stores, distributes, or uses human tissue including musculoskeletal tissue, skin, cardiovascular tissue, ocular tissue, and reproductive tissue for transplantation.

How does AATB accreditation relate to CDPH licensing?

AATB accreditation is a voluntary private-sector credential that documents compliance with the Standards for Tissue Banking. In a CCP § 1021.5 fee petition, AATB standards function as Ketchum advisory evidence to calibrate reasonable hours — they demonstrate the scope of donor screening, processing validation, and traceability documentation an unlicensed tissue bank failed to maintain.

How does EBAA accreditation differ from AATB accreditation for fee petition purposes?

EBAA Medical Standards govern ocular tissue (corneas, sclera) specifically — slit-lamp evaluation, specular microscopy endothelial cell counts, corneal preservation media protocols, and surgical viability criteria. AATB Standards cover the broader tissue banking enterprise. A tissue bank operating without either credential lacks the documentation framework that the Ketchum lodestar uses to measure reasonable enforcement hours.

Is PURE KETCHUM available on an unlicensed tissue bank enforcement action?

Yes. PURE KETCHUM applies when (1) the fee petition rests solely on CCP § 1021.5 with no concurrent federal fee-shifting statute, and (2) the private professional standards (AATB, EBAA) are used only as Ketchum advisory evidence — not as independent fee-shifting claims. Burlington Northern v. Dague (1992) does not apply because 28 U.S.C. § 1988 is not at issue.

What is the Welch declaration proof structure for a tissue bank case?

The Welch declaration establishes unlicensed status via: (1) CDPH HFIS showing no active Tissue Bank license, (2) FDA FURLS showing no tissue establishment registration under 21 CFR Part 1271, (3) AATB directory showing no accreditation, (4) EBAA directory showing no accreditation for eye bank operations, and (5) CDPH inspection reports documenting specific deficiencies — absent donor infectious disease testing, missing processing validation, no donor eligibility determination records.

Track Your Tissue Bank Enforcement Hours — Automatically

ClaimHour captures every billable tenth-of-an-hour across CDPH license research, AATB/EBAA standards review, Welch declaration drafting, and hearing prep — without a practice management system.

Start Free Trial